X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
FDC LTD. Fact Sheet, FDC LTD. Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. Fact Sheet   (FDCL)

Here is the latest financial fact sheet of FDC LTD.. For more details, see the FDC LTD. quarterly results and FDC LTD. share price and chart. For a sector overview, read our pharmaceuticals sector report.

FDC LTD. Price History

Price Rs 183.2
Mkt Cap Rs m 32,570
Vol '000 2.4
P/E X 18.5
P/CF X 17.8
EPS (TTM) Rs 9.9
% ch % -0.3
No. of shares m 177.83
% ch week % 0.5
% ch 1-mth % 5.5
% ch 12-mth % 2.0
52 week H/L Rs 240.0/165.5
(As on Jun 23, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

FDC LTD. Financials

No. of Mths
Year Ending
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
5-Yr Chart
Click to enlarge
FDC LTD. EQUITY SHARE DATA
High Rs84118111106144 
Low Rs3179767579 
Sales per share (Unadj.) Rs33.938.638.842.747.6 
Earnings per share (Unadj.) Rs8.08.27.38.67.6 
Diluted earnings per shareRs8.48.57.58.77.6 
Cash flow per share (Unadj.) Rs8.99.18.310.19.0 
Dividends per share (Unadj.) Rs1.752.002.002.252.25 
Adj. dividends per shareRs1.832.082.062.292.25 
Dividend yield (eoy) %3.02.02.12.52.0 
Book value per share (Unadj.) Rs28.333.438.043.447.5 
Adj. book value per shareRs29.634.739.144.147.5 
Shares outstanding (eoy) m186.28184.57182.92180.83177.83 
Bonus/Rights/Conversions  BBBBBBBBBB 
Price / Sales ratio x1.72.62.42.12.3 
Avg P/E ratio x7.212.012.810.514.6 
P/CF ratio (eoy) x6.510.811.28.912.3 
Price / Book Value ratio x2.02.92.52.12.3 
Dividend payout %21.924.527.326.229.6 
Avg Mkt Cap Rs m10,71118,18017,10316,36519,784 
No. of employees `000NANANANANA 
Total wages/salary Rs m7248569901,0751,221 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
FDC LTD. INCOME DATA
Net Sales Rs m6,3217,1177,1057,7288,459 
Other income Rs m314283278463394 
Total revenues Rs m6,6367,3997,3838,1928,852 
Gross profit Rs m1,6621,6591,6431,8092,070 
Depreciation Rs m159174184279249 
Interest Rs m1114141631 
Profit before tax Rs m1,8061,7541,7221,9772,184 
Minority Interest Rs m00000 
Prior Period Items Rs m-23-1732-225 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m292228384427606 
Profit after tax Rs m1,4911,5091,3411,5521,353 
Gross profit margin %26.323.323.123.424.5 
Effective tax rate %16.213.022.321.627.7 
Net profit margin %23.621.218.920.116.0 
FDC LTD. BALANCE SHEET DATA
Current assets Rs m1,6464,4694,4404,0734,355 
Current liabilities Rs m1,2441,2351,3691,5041,792 
Net working cap to sales %6.445.443.233.230.3 
Current ratio x1.33.63.22.72.4 
Inventory Days Days5250534744 
Debtors Days Days2121222025 
Net fixed assets Rs m2,8562,8693,0382,9643,025 
Share capital Rs m187185184182179 
"Free" reserves Rs m4,9165,9676,7377,6288,243 
Net worth Rs m5,2666,1646,9547,8428,453 
Long term debt Rs m4625201511 
Total assets Rs m6,7957,6978,6289,66310,557 
Interest coverage x166.7122.8123.1124.671.4 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.90.80.80.8 
Return on assets %22.119.815.716.213.1 
Return on equity %28.324.519.319.816.0 
Return on capital %33.828.324.925.423.5 
Exports to sales %8.89.411.812.113.3 
Imports to sales %7.34.24.03.63.3 
Exports (fob) Rs m5596708419371,126 
Imports (cif) Rs m461296286279283 
Fx inflow Rs m5626728459591,146 
Fx outflow Rs m478315310347355 
Net fx Rs m83357534612791 
FDC LTD. CASH FLOW
From Operations Rs m 1,686 1,207 1,443 1,499 1,485 
From Investments Rs m -1,270 -330 -1,083 -1,072 -620 
From Financial Activity Rs m -373 -575 -582 -628 -753 
Net Cashflow Rs m 43 302 -221 -201 113 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 68.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 4.7%
FIIs 7.5%
ADR/GDR 0.0%
Free float 19.0%
Shareholders 23,730
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF B-8, MIDC Industrial Estate, Waluj Dist., Aurangabad - 431 136
E-MAIL investors@fdcindia.com WEB www.fdcindia.com
TELEPHONE (0240) 255 4407 FAX (0240) 255 4299
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharex Dynamic, 1, Luthra Indl. Estate, Safed Pool, Andheri (E), Mumbai-72
AUDITOR S. R. Batliboi & Co.
CHM: M. A. Chandavarkar (MD) COMP SEC: Varsharani Katre YEAR OF INC: 1900 BSE CODE: 531599 FV (Rs): 1 DIV YIELD (%): 1.2

More Pharmaceuticals Company Fact Sheets:   NATCO PHARMA  IPCA LABS  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare FDC LTD. With:   NATCO PHARMA  IPCA LABS  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare FDC LTD. With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Share Markets End the Week on a Dull Note(RoundUp)

Global financial markets ended the week on a dull note. This was on back of the Federal Reserve's release of its May 2-3 policy meeting minutes.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

A Pharma IPO in a Market That Loves IPOs but Hates Pharma(The 5 Minute Wrapup)

Jun 15, 2017

Tomorrow comes the IPO of Eris Lifesciences. How will a pharma IPO do in this market?

Bitcoin at $10,000?(Vivek Kaul's Diary)

Jun 14, 2017

Whether you're Venezuela or China or in India or the US...and you want to protect your wealth, you need real money. All the government has on offer is funny money.

Get Ready for Commodity Options!(Daily Profit Hunter)

Jun 16, 2017

Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.

Walter Schloss' Investing Record(Chart Of The Day)

Jun 17, 2017

In a market full of one-hit-wonders, this investor obviously had a formula that worked. And through the think-and-thin of the market.

11 Hidden Costs Associated With Your Home Loan(Outside View)

Jun 16, 2017

Various costs associated with a home loan.

More

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FDC LTD.

FDC LTD. - DR. REDDYS LAB COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS